STMN Share Price Performance
CHF 103.20
-2.70 (-2.55%)
31.2% undervalued intrinsic discount
CHF 150.00
Fair Value
Price CHF 103.20
AnalystHighTarget CHF 150.00
AnalystConsensusTarget CHF 125.00
AnalystLowTarget CHF 89.00
Fair ValueCHF 150.00
Share PriceCHF 103.20
31.2% undervalued intrinsic discount
STMN Community Narratives
AN
Fair Value CHF 150.00 31.2% undervalued intrinsic discount
Digital Dentistry And Global Aging Trends Will Boost Market Opportunities
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value CHF 125.00 17.4% undervalued intrinsic discount
iEXCEL And AXS Platforms Will Drive Market Share Gains In Implantology
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
Fair Value CHF 89.00 16.0% overvalued intrinsic discount
Global Cost Pressures And Tariff Risks Will Hurt Dental Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
STMN Community Fair Values
- CHF 150.00FV31.2% undervalued intrinsic discount12.11%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative13 days ago author updated this narrative
- CHF 89.00FV16.0% overvalued intrinsic discount7.17%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative13 days ago author updated this narrative
- CHF 125.00FV17.4% undervalued intrinsic discount8.62%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative10users have followed this narrative6 days ago author updated this narrative
Recent STMN News & Updates
No updates
Straumann Holding AG Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 13, 2025
- Earnings per share (EPS)
- 2.87
- Gross Margin
- 71.40%
- Net Profit Margin
- 18.28%
- Debt/Equity Ratio
- 9.8%
Straumann Holding AG Competitors
About STMN
- Founded
- 1954
- Employees
- 11579
- CEO
- WebsiteView website
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company also offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made of ceramics, metal or polymer; clear aligners and made of polymer; and biomaterials for tissue generation. In addition, it provides restorative solutions comprising abutments and related parts, as well as milling elements. Further, it provides digital equipment comprising scanners, milling machines, and 3D printers; software licenses; and training and other miscellaneous products. The company provides its products to general dentists, specialists, and dental technicians and laboratories through a network of distribution subsidiaries and partners, and third-party distributors. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Swiss Market Performance
- 7 Days: -1.1%
- 3 Months: -2.0%
- 1 Year: 3.1%
- Year to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.4% in the Healthcare sector. As for the longer term, the market has actually risen by 3.1% in the last year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading